430 related articles for article (PubMed ID: 28813195)
1. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
3. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
Vosshenrich J; Zech CJ; Heye T; Boldanova T; Fucile G; Wieland S; Heim MH; Boll DT
Eur Radiol; 2021 Jun; 31(6):4367-4376. PubMed ID: 33274405
[TBL] [Abstract][Full Text] [Related]
4. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
6. Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib.
Fu S; Chen S; Liang C; Liu Z; Zhu Y; Li Y; Lu L
Oncotarget; 2017 Jun; 8(23):37855-37865. PubMed ID: 27911268
[TBL] [Abstract][Full Text] [Related]
7. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography.
Fujita T; Ito K; Tanabe M; Yamatogi S; Sasai H; Matsunaga N
J Vasc Interv Radiol; 2008 Mar; 19(3):333-41. PubMed ID: 18295691
[TBL] [Abstract][Full Text] [Related]
8. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response.
Miyayama S; Yamashiro M; Ikuno M; Okumura K; Yoshida M
Abdom Imaging; 2014 Jun; 39(3):645-56. PubMed ID: 24549881
[TBL] [Abstract][Full Text] [Related]
9. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma.
Li M; Fu S; Zhu Y; Liu Z; Chen S; Lu L; Liang C
Oncotarget; 2016 Mar; 7(11):13248-59. PubMed ID: 26910890
[TBL] [Abstract][Full Text] [Related]
11. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
12. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
Eur Radiol; 2016 Jan; 26(1):225-34. PubMed ID: 25991485
[TBL] [Abstract][Full Text] [Related]
13. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.
Zhang W; Xu AH; Wang W; Wu YH; Sun QL; Shu C
BMC Cancer; 2019 Nov; 19(1):1041. PubMed ID: 31690274
[TBL] [Abstract][Full Text] [Related]
14. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
16. Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma.
Yu JY; Zhang HP; Tang ZY; Zhou J; He XJ; Liu YY; Liu XJ; Guo DJ
Clin Radiol; 2018 Aug; 73(8):758.e9-758.e18. PubMed ID: 29804627
[TBL] [Abstract][Full Text] [Related]
17. Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma.
Reis SP; Sutphin PD; Singal AG; Grzybowski R; Fisher S; Ball C; Xi Y; Grewal S; Kalva SP
J Comput Assist Tomogr; 2017; 41(2):289-293. PubMed ID: 27824665
[TBL] [Abstract][Full Text] [Related]
18. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
Kim SH; Lee WJ; Lim HK; Lim JH
J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
[TBL] [Abstract][Full Text] [Related]
19. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma.
Habbel VSA; Zeile M; Stavrou GA; Wacker F; Brüning R; Oldhafer KJ; Rodt T
Abdom Radiol (NY); 2019 Oct; 44(10):3463-3479. PubMed ID: 31332502
[TBL] [Abstract][Full Text] [Related]
20. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
